Nanobiotix S.A. NBTX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -61.67M | -44.79M | -27.56M | -41.40M | -55.97M |
| Total Depreciation and Amortization | 1.72M | 1.72M | 1.68M | 1.72M | 1.77M |
| Total Amortization of Deferred Charges | 5.90K | 4.20K | 2.40K | 3.30K | 4.30K |
| Total Other Non-Cash Items | 31.08M | 11.40M | -7.76M | 4.02M | 16.28M |
| Change in Net Operating Assets | -11.02M | -7.53M | -4.09M | -55.90K | 4.02M |
| Cash from Operations | -39.88M | -39.19M | -37.72M | -35.71M | -33.89M |
| Capital Expenditure | -1.18M | -904.50K | -616.60K | -581.10K | -550.50K |
| Sale of Property, Plant, and Equipment | 61.80K | 31.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.50K | -38.90K | -45.80K | -81.70K | -119.20K |
| Cash from Investing | -1.15M | -912.40K | -662.40K | -662.80K | -669.70K |
| Total Debt Issued | 42.93M | 42.93M | 42.93M | 21.47M | -- |
| Total Debt Repaid | -4.40M | -4.57M | -4.74M | -4.67M | -4.60M |
| Issuance of Common Stock | 78.49M | 40.01M | 1.54M | 767.50K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -288.00K | -1.30M | -2.31M | -1.51M | -707.00K |
| Cash from Financing | 136.18M | 90.09M | 43.86M | 19.11M | -5.78M |
| Foreign Exchange rate Adjustments | 593.90K | 71.40K | -431.30K | -469.90K | -508.00K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 100.00 | -500.00 | -1.10K |
| Net Change in Cash | 95.74M | 50.06M | 5.04M | -17.73M | -40.85M |